In another report, inhibition of phosphoglycerate dehydrogenase (PHGDH) using the inhibitor NT-503, significantly potentiated the cytotoxic effect of bortezomib in seven out of eight tested MM cell lines [43]. The gene discussed is PHGDH; the disease is Miyoshi myopathy.